Zhang Longcheng, Jiang Renjing, Men Xiaoguang, Liu Guoshi, Zhong Hailin, Sun Tao
Department of Otorhinolaryngology, 303 Hospital of PLA, Nanning 530021, China.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Dec;37(6):447-9.
To evaluate the effect of endoscopic transnasal orbital decompression for patients with dysthyroid orbitopathy.
Nine cases (15 eyes) of dysthyroid orbitopathy were included in this study. All patients were treated by transnasal endoscopic orbital decompression.
The follow-up ranged from 6 months to 2 years. Proptosis measured' by exophthalmoter reduced from (21.93 +/- 1.49) mm to (16.87 +/- 1.25) mm after operation. The visual acuity improved from 0.57 +/- 0.12 to 0.69 +/- 0.12, the palperbral fissures reduced from (11.07 +/- 1.44) mm to (8.20 +/- 1.15) mm. Postoperatively, the orbital pressure was significantly decreased as compared with the preoperative result (P < 0.001). Diplopia was cured in 3 of 7 cases.
Endoscopic transnasal orbital decompression is an effective method for the treatment of dysthyroid orbitopathy.
评估经鼻内镜眼眶减压术治疗甲状腺相关眼病患者的效果。
本研究纳入9例（15只眼）甲状腺相关眼病患者。所有患者均接受经鼻内镜眼眶减压术治疗。
随访时间为6个月至2年。术后，眼球突出度由（21.93±1.49）mm降至（16.87±1.25）mm。视力由0.57±0.12提高至0.69±0.12，睑裂由（11.07±1.44）mm降至（8.20±1.15）mm。术后眼眶压力较术前显著降低（P<0.001）。7例中有3例复视治愈。
经鼻内镜眼眶减压术是治疗甲状腺相关眼病的有效方法。
